跳至主要内容
临床试验/ACTRN12621001327875
ACTRN12621001327875尚未招募4 期

A prospective, randomised non-blinded pilot study to investigate the effect of oral tranexamic acid on the recovery time in patients undergoing primary total knee arthroplasty.

Wesley Medical Research0 个研究点目标入组 80 人开始时间: 2021年9月29日最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
50 Years 至 o limit(—)
性别
All

入选标准

  • 1. Participants of either sex scheduled to undergo a primary, unilateral Total Knee Arthroplasty.
  • 2. Available for follow up at 6 months post-surgery.
  • 3. Willingness to provide written, informed consent.
  • 4. Willingness to comply with the study.

排除标准

  • 1. Known allergy to TXA
  • 2, Acquired disturbances to colour vision
  • 3, Preoperative use of anticoagulants (within 5 days of surgery)
  • 4. Fibrinolytic disorders requiring intraoperative fibrinolytics
  • 5. Coagulopathy, history of arteriolar or venous thromboembolic disease
  • 6. Pregnancy or breastfeeding
  • 7. Haemoglobin <10g/dL

研究者

相似试验